D3 receptor expression within the basal ganglia is not affected by Parkinson's disease☆
References (18)
- et al.
Changes in brain dopamine receptors in MPTP parkinsonian monkeys following l-dopa treatment
Brain Res.
(1993) - et al.
Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA
Brain Res.
(1991) - et al.
Effect of chronic treatment of MPTP monkeys with dopamine D1 and/or D2 receptor agonists
Eur. J. Pharmacol.
(1990) - et al.
Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism
Brain Res.
(1993) - et al.
Autoradiographic distribution of D3-type dopamine receptors in human brain using [3H]7-hydroxy-N,N-di-N-propyl-2-aminotetralin
Brain Res.
(1994) Parkinson's disease and its chemotherapy
Biochem. Pharmacol.
(1975)- et al.
Dopamine D3 receptors in the basal ganglia of the common marmoset and following MPTP and l-DOPA treatment
Brain Res.
(1996) - et al.
Dopamine D3 receptor mRNA and binding sites in human brain
Mol. Brain Res.
(1993) - et al.
The dopamine D3 receptor: Chinese hamsters of Chinese whispers
Trends Pharmacol. Sci.
(1994)
There are more references available in the full text version of this article.
Cited by (0)
- ☆
This work was supported by grants from the Parkinson's Disease Society, Medical Research Council and National Parkinson's Foundation, Miami, USA.
- ∗
M.J.H. was the recipient of a Glaxo Prize Scholarship.
Copyright © 1996 Published by Elsevier Ireland Ltd.